Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.